ENTPD1 (CD39), a gene associated with T cell exhaustion, was previously nominated as a marker for tumor-reactive TIL in lung cancer2 and indeed was upregulated in tumor-reactive TIL relative to bystander TIL in the melanoma dataset used here2,11. This evidence concerns the gene ENTPD1 and melanoma.